Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cardiovascular Systems

Cardiovascular Systems
1989 FOUNDED
PUBLIC STATUS
601-700 EMPLOYEES
CSII STOCK SYMBOL
1 INVESTMENTS
$39.69 SHARE PRICE (As of Friday Closing)
Description

Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generates the vast majority of its revenue in the United States.

Website
Formerly Known As
Shturman Cardiology Systems
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Stock Exchange
NAS
Primary Office
  • 651 Campus Drive
  • New Brighton, MN 55112
  • United States

+1 (651) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cardiovascular Systems’s full profile, request a free trial.

Cardiovascular Systems Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$20.89 - $42.64 $1.41B $40.47 $0.05 487K 34.8M

Cardiovascular Systems Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
FY 2016
30-Jun-2016
Enterprise Value 895,811 986,762 975,843 538,479
Revenue 231,211 217,043 204,906 178,184
EBITDA 5,206 6,168 2,593 (52,160)
Net Income 1,706 1,712 (1,792) (56,024)
Total Assets 207,187 203,352 193,940 142,406
Total Debt 21,025 21,064 21,100 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cardiovascular Systems Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cardiovascular Systems‘s full profile, request access.

Request full access to PitchBook

Cardiovascular Systems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Cardiovascular Systems‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Cardiovascular Systems Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 25-Feb-2009 000000000000000000 Biotechnology 00000 000000
To view this company’s complete investment and acquisition history, request access »

Cardiovascular Systems Subsidiaries (1)

Company Name Industry Location Founded
000000000 Biotechnology Louisville, CO 0000
To view this company’s complete subsidiary history, request access »

Cardiovascular Systems Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Cardiovascular Systems‘s full profile, request access.

Request full access to PitchBook

Cardiovascular Systems Executive Team (11)

Name Title Board
Seat
Contact
Info
Laurence Betterley Chief Financial Officer
James Flaherty Chief Administrative Officer
Kevin Kenny Chief Operating Officer
Paul Koehn Senior Vice President, Quality and Operations
Robert Thatcher Chief Healthcare Policy Officer

2 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

Cardiovascular Systems Board Members (8)

Name Representing Role Since Contact
Info
Brent Blackey Self Board Member 000 0000
Glen Nelson MD Self Chairman 000 0000
Leslie Trigg Self Board Member 000 0000
Scott Ward Cardiovascular Systems President, Chief Executive Officer & Chairman 000 0000

4 Former Board Members

You’re viewing 4 of 8 board members. Get the full list »